Methotrexate Sodium
NDC Package 75840-111-00

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Methotrexate Sodium is methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. Marketed by Genpak Solutions Llc, this product is identified by NDC 75840-111 and is authorized under FDA application NDA008085.

Identification & Billing

NDC Package Code
75840-111-00
Package Description
10 BOX in 1 BLISTER PACK / 100 TABLET in 1 BOX (75840-111-01)
Product Code
75840-111
11-Digit Billing Format
75840011100

Clinical Specifications

Proprietary Name
Methotrexate Sodium
Dosage Form
-
Usage Information
Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis. Methotrexate belongs to a class of drugs known as antimetabolites. It works by slowing or stopping the growth of cancer cells and suppressing the immune system. Early treatment of rheumatoid arthritis with more aggressive therapy such as methotrexate helps to reduce further joint damage and to preserve joint function.

Regulatory & Marketing

Labeler Name
Genpak Solutions Llc
FDA Application #
NDA008085
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
10-01-2012
Listing Expiration
12-31-2018
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 75840-111-00 identifies a specific commercial package of 10 box in 1 blister pack / 100 tablet in 1 box (75840-111-01) of Methotrexate Sodium, labeled by Genpak Solutions Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Genpak Solutions Llc on October 01, 2012. The current certification is valid through December 31, 2018.

What are the primary indications for this medication?

Methotrexate is used to treat certain types of cancer or to control severe psoriasis or rheumatoid arthritis. It may also be used to control juvenile rheumatoid arthritis. Methotrexate belongs to a class of drugs known as antimetabolites. It works by slowing or stopping the growth of cancer cells and suppressing the immune system. Early treatment of rheumatoid arthritis with more aggressive therapy such as methotrexate helps to reduce further joint damage and to preserve joint function.

How is this Genpak Solutions Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 75840011100. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
75840-111-00
11-Digit CMS (5-4-2)
75840-0111-00

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.